Nancy, If you don't have profits now, and you entered at around the current price, I think you have a small chance of a pop to an area of profit if you're lucky. If you're hoping the stock to get back to 45, I expect that you are risking larger losses. Keep your eye on the whole picture, rather than where you "need" the stock to be. We all make that mistake.
As for other products, perhaps you don't realize how many years it is from "starting Phase I" to approval and the company making money on it, even if all trials prove out? It was over a year ago that Claud was hyping the stock on the basis of "Vasomaxine." Now they are starting Phase I testing. Remember, stocks FAIL Phase III. I owned a company and lost a bundle on that one, when the excitedly expected drug failed Phase III. The stock went from 26, where I had bought, to 5. I think I got out at 6 or 7.
If Vasomax fails FDA, investors will not trust that Vasomaxine to pass, so the runups in advance of FDA approval of Vasomaxine, as happened with Vasomax, will be minimized. Then there will be years wait to finish (and pass) trials.
There are a lot of people here who are long and have big money on the line, and they aren't going to advise anyone to sell until they've gotten out and they've gotten their clients out. They're only your "friend" as long as you stay long, because that helps them financially.
Linda |
